Our research expertise spans cancer genomics, DNA damage, RNA biology, and drug development. We are also expanding our focus on drug delivery, particularly through nanotechnology-based methods for delivering small RNA mimics and inhibitors.
Registration is now open!
News
- Biomolecular NMR Assignments: The 1H, 15N and 13C backbone resonance assignments of the N-terminal (1-149) domain of Serpine mRNA Binding Protein 1 (SERBP1) (Libich Lab)
- Int’l Journal of Molecular Sciences: The Role of the Tumor Microenvironment (TME) in Advancing Cancer Therapies: Immune System Interactions, Tumor-Infiltrating Lymphocytes (TILs), and the Role of Exosomes and Inflammasomes (Aune Lab)
- Progress in Neurobiology: Pathogenic Oligomeric Tau alters Neuronal RNA Processes through the Formation of Nuclear Heteromeric Amyloids with RNA-Binding Protein Musashi1 (Penalva)
- Texas Public Radio: Science & Medicine: Sabotaging the molecular engines of some pediatric cancers (Gupta)
- ELife: SERBP1 interacts with PARP1 and is present in PARylation-dependent protein complexes regulating splicing, cell division, and ribosome biogenesis (Libich, Penalva, et al)
Events
Greehey CCRI Seminar Series: Gang Huang (UTHSA, Department of Cell Systems and Anatomy)
Presentation title: TBD
Greehey CCRI Seminar Series: Andrew J Brenner, MD, PhD (UTHSA – Dept Cell Systems and Anatomy)
Presentation title: TBD
4th Annual Gear Up Against Kids Cancer Bike Ride
With cycling becoming an increasingly popular activity in San Antonio and south Texas, the Gear Up Against Kids Cancer was launched on April 2, 2022, to address a critical need for increased support for pediatric cancer research.